Melanoma risk in families and individuals
Part of Cancer, Genetic & congenital, Skin clinical trials.
This study looks at people and families with a high risk of melanoma, especially if it runs in the family or is linked to certain genetic conditions. The goal is to better understand what causes melanoma and how to detect it earlier.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be at least 4 weeks old.
- You or a family member must have a history of melanoma, especially if it was unusual, occurred at a young age, or involved multiple cases in the family.
- You or a family member must have a known or suspected genetic or congenital condition that increases melanoma risk, such as giant congenital nevi or dysplastic nevi.
- You or a family member must have a history of certain other cancers or conditions like retinoblastoma, Hodgkin's lymphoma, or an immunodeficiency syndrome.
- You must be able to provide informed consent yourself or have a legal guardian who can.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks for genetic and environmental causes of melanoma in people up to age 30. It may help researchers understand why some young people get this type of skin cancer.
This study looks at the DNA and other biology from skin lesions (like melanoma or unusual pigmented moles) in children and teens. It aims to better understand what these tumors are and how they behave, using tissue samples collected during routine care.
This study looks at diagnostic and prognostic factors in people who have suspicious pigmented skin lesions or melanoma that doctors are evaluating with surgery or tissue sampling. It may help improve how clinicians decide what the lesion is and what to expect over time.
This trial studies whether certain gene patterns and a blood test can help predict how melanoma might behave. It is for people with a thicker melanoma (greater than 2 mm) that has not spread to lymph nodes or other parts of the body, and who are planning to have a sentinel lymph node biopsy.
This study looks at people who have rare or unusual cancers or who may have an inherited (family) risk for cancer. It helps researchers learn what genetic or other factors might be involved by collecting family history and medical records, including pathology slides.
This study helps doctors decide the safest surgical approach for melanoma and similar skin tumors in children and young adults by using pathology reports and genetic information. The goal is to avoid unnecessary surgery while ensuring the best outcomes.
Hear when a new Melanoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.